ANAB - AnaptysBio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$83.14
DETAILS
HIGH:
$140.00
LOW:
$50.00
MEDIAN:
$76.00
CONSENSUS:
$83.14
UPSIDE:
39.24%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 99.0% |
| EBIT Margin | 20.4% |
| EBITDA Margin | 21.4% |
| Operating Margin | 20.4% |
| Pretax Margin | -5.6% |
| Cont. Ops Margin | -5.6% |
| Net Margin | -5.6% |
| Bottom Line Margin | -5.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 9.07 |
| Quick Ratio | 9.07 |
| Solvency Ratio | -0.033 |
| Cash Ratio | 6.17 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-67.88
Peers avg: 22.9
|
| PEG Ratio | 0.75 |
| Forward PEG | 0.75 |
| Price/Book | 24.14 |
| Price/Sales | 3.83 |
| Price/FCF | 45.80 |
| Price/Op Cash Flow | 45.60 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0387 |
| Debt/Equity | 0.3793 |
| Debt/Capital | 0.2750 |
| Long-Term Debt/Capital | 0.2443 |
| Financial Leverage | 9.79 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.67 |
| Operating Cash Flow Ratio | 0.510 |
| Operating Cash Flow/Sales | 8.4% |
| Free Cash Flow/Operating Cash Flow | 99.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.61 |
| Interest Coverage | 0.5995 |
| Short-Term Operating Cash Flow Coverage | 9.47 |
| Operating Cash Flow Coverage | 1.40 |
| Capital Expenditure Coverage | 226.40 |
| Dividend + Capital Expenditure Coverage | 226.40 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 8.44 |
| EPS | -0.476 |
| Debt/Share | 3.3828 |
| Cash/Share | 11.21 |
| Book Value/Share | 1.34 |
| Tangible BV/Share | 1.34 |
| Equity/Share | 1.34 |
| Operating Cash Flow/Share | 0.709 |
| Capital Expenditure/Share | 0.003 |
| FCF/Share | 0.706 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.013 |
| Earnings Before Tax/EBIT | -0.273 |
| Price/Fair Value | 24.14 |
| Debt/Market Cap | 0.0157 |
| Effective Tax Rate | -1.3% |
| Enterprise Value Multiple | 13.40 |